Request to Join
has invited you to join this group
Salim S. Abdool Karim is a South African clinical infectious diseases epidemiologist who is widely recognised for his research contributions in HIV prevention and treatment. He is Director of the Centre for the AIDS Program of Research in South Africa (CAPRISA) and CAPRISA Professor of Global Health at Columbia University. He is Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal, South Africa, Adjunct Professor of Immunology and Infectious Diseases, Harvard University, Boston and Adjunct Professor of Medicine at Cornell University, New York. He is also an Associate of The Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard University. Dr Abdool Karim is Chair of the UNAIDS Scientific Expert Panel, WHO’s HIV Strategic and Technical Advisory Committee as well as the WHO TB-HIV Task Force. He is a member of the Scientific Advisory Board for Global Health of the Bill and Melinda Gates Foundation. He is a Fellow of the Royal Society and a member of the US National Academy of Medicine, the American Academy of Microbiology and the Association of American Physicians. He is a member of the Editorial Board of the New England Journal of Medicine.
Dr. Stephen Baum is currently emeritus professor of medicine and of microbiology & immunology, as well as senior advisor for student affairs. After joining the faculty as a research associate in 1968, Dr. Baum became, in rapid succession, director of the infectious disease service at Einstein Hospital, director of Einstein’s Medical Scientist Training Program (MD-PhD), one of the original chiefs of the department of medicine’s division of infectious diseases, and director of the office of graduate education. After moving to Beth Israel Medical Center in 1987 to chair its department of medicine, he returned to Einstein in 2007, where he began his role as dean for student affairs. . For the past decade, his sage counsel has guided Einstein students along their journey through medical school, into residency and, ultimately, into practice. Dr. Baum is a member of the editorial boards of Clinical Infectious Diseases, Infectious Diseases and Journal Watch Infectious Diseases, and author of numerous book chapters and peer-reviewed articles. Early in his career he was chosen as Career Scientist by the Health Research Council of the City of New York. His excellence in teaching medical students has led to being elected twice to the Leo M. Davidoff Society―in 1980 and in 1996. He also was presented Einstein’s Lifetime Achievement Award for Excellence in Teaching in 2008. Dr. Baum earned his undergraduate degree at Cornell University and his medical degree at New York University School of Medicine. He completed his internship and residency at Harvard Medical Service – Boston City Hospital, and spent two years as a research associate at the NIH’s National Institute of Allergy and Infectious Diseases. He is a Fellow of The American College of Physicians and the infectious Diseases Society of America.
Daniel Kaul, MD, is Professor of Medicine at the University of Michigan Medical School in Ann Arbor. He directs the Transplant Infectious Disease Service and serves as Infectious Disease Fellowship Program Director. His research interests include infectious complications of solid-organ and stem-cell transplantation. He is past chair of the United Network for Organ Sharing’s Disease Transmission Advisory Committee and serves on the education committee of the American Society of Transplantation and the program directors committee of the Infectious Disease Society of America. He has written for NEJM Journal Watch Infectious Diseases since 2017.
Thomas Glück, MD, is Professor of Medicine at the University of Regensburg, Chief, Department of Internal Medicine, District Hospital Trostberg, and Chief, Infectious Diseases Consulting Service, District Hospitals, Traunstein and Trostberg, Bavaria, Germany. A member of the Bavarian infectious diseases specialty board, he received his specialty training in the U.S. His research interests include clinical sepsis, pathogenesis of sepsis, endocarditis, and infections in immunocompromised patients. Dr. Glück has been writing for NEJM Journal Watch Infectious Diseases since 2004.
Carlos del Rio, MD, is Hubert Professor and Chair of the Hubert Department of Global Health, Rollins School of Public Health at Emory University, and Co-Director of the Emory Center of AIDS Research. He is also the Program Director and Principal Investigator of the Emory AIDS International Training and Research Program. His research interests include the epidemiology of opportunistic infections in HIV, the epidemiology and transmission dynamics of HIV and other sexually transmitted diseases, early diagnosis of HIV, linkage to and retention in HIV care, and prevention of HIV infection. In addition, Dr. del Rio's interests include the optimization of HIV management in resource-constrained countries. He was a member of the NEJM Journal Watch AIDS Clinical Care Editorial Board since 1998 and Editor-in-Chief in 2014. Dr. del Rio has been a member of the NEJM Journal Watch Infectious Diseases Editorial Board since May 2014.
Dr. George Sakoulas is an active infectious disease clinician in the Sharp Healthcare System, San Diego, CA, and an Associate Adjunct Professor in the Division of HostMicrobe Systems and Therapeutics, Center for Immunity, Infection and Inflammation at the University of California San Diego School of Medicine. Dr. Sakoulas is also an investigator in the UCSD Health Sciences interdisciplinary research and educational initiative called the “Collaborative to Halt Antibiotic-Resistant Microbes” or CHARM. As a CHARM investigator, Dr. Sakoulas is involved in creative ‘outside the box’ research that can provide innovative diagnostic and therapeutic solutions to the burgeoning antibioticresistance in the context of judicious antimicrobial stewardship. One unique approach to this problem employed by Dr. Sakoulas is deriving a scientifically-based therapeutic plan in patients with the most complex invasive infections, such as Staphylococcus aureus bacteremia, and then employing translational research to validate such treatments for clinical use. Treatment plans for such complex ‘outlier’ cases are frequently unable to be validated from standard clinical trial methods, leaving these types of approaches as the most direct way to provide clinical guidance.
Dr. Sakoulas is the author or coauthor of more than 150 scientific publications and has written several book chapters and scientific abstracts in the areas of infectious diseases. He lectures extensively on topics such as treatment options against complex infections caused by methicillin-resistant S aureus (MRSA), vancomycin-resistant Enterococcus spp,and other multidrug-resistant pathogens. His research interests include investigating the relationships between antimicrobial resistance and virulence mechanisms in S aureus and host response characteristics that may potentially be used as prognostic markers. In addition, he is actively studying the vastly underappreciated interactions between innate host defense and administered antimicrobial drugs.